Noticias de ONCY_US
Noticias del mercado
Últimas noticias sobre ONCY_US — 193 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Oncolytics Biotech(R) Reports 2019 Third Quarter Financial Results and Operational Highlights
ONCY News | ONCOLYTICS BIOTECH INC (NASDAQ:ONCY)
Pelareorep, un virus oncolítico administrado sistémicamente, está avanzando en los ensayos sobre cáncer gastrointestinal con datos preliminares prometedores, especialmente en el cáncer colorrectal metastásico de segunda línea. Los catalizadores clave a corto plazo incluyen resultados provisionales de un nuevo estudio controlado y actualizaciones sobre la protección de patentes. Basado en Oncolytics...
Oncolytics Biotech (ONCY) COO discloses 500,000-share stock option holding
ONCOLYTICS BIOTECH (ONCY) director receives 30,000 stock options at $1.06
Oncolytics Biotech (NASDAQ: ONCY) grants director Rigby 30,000 options
Oncolytics Biotech (NASDAQ: ONCY) grants director 30,000 options
ONCOLYTICS BIOTECH (NASDAQ: ONCY) director granted options on 30,000 shares at $1.06
ONCOLYTICS (ONCY) CFO receives 260,000 stock options at $1.06 exercise price
Oncolytics Biotech (NASDAQ: ONCY) CBO receives 260,000 stock options at $1.06 exercise price
Oncolytics Biotech (NASDAQ: ONCY) director Stephen Glover files initial Form 3
Oncolytics Biotech (NASDAQ: ONCY) CEO awarded 755,000 options at $1.06 strike
ONCOLYTICS BIOTECH (ONCY) director receives 30,000 stock options grant at $1.06
ONCOLYTICS (NASDAQ: ONCY) director awarded stock options on 30,000 shares
ONCOLYTICS BIOTECH (NASDAQ: ONCY) CTO awarded 260,000 stock options at $1.06 strike
ONCOLYTICS BIOTECH (ONCY) director receives stock options on 30,000 shares
ONCOLYTICS BIOTECH (ONCY) CMO awarded 260,000 stock options at $1.06
145,000 stock options granted to Oncolytics (ONCY) COO McAdory
ONCOLYTICS BIOTECH (NASDAQ: ONCY) director receives 96,000 stock options at $1.06
Oncolytics Biotech Strengthens Leadership with New COO, Director
Página 1 de 10
